Literature DB >> 11728661

Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?

E Kucera1, G Sliutz, K Czerwenka, G Breitenecker, S Leodolter, A Reinthaller.   

Abstract

OBJECTIVE: To investigate whether high-risk HPV infection associated with cervical intraepithelial neoplasia (CIN) was successfully eliminated after electrosurgical conization by large-loop excision of the transformation zone (LLETZ). STUDY
DESIGN: 142 women, who were admitted for conization of CIN 1-3 were recruited into a prospective follow-up study of HPV infection, including cervical sampling for HPV DNA before, and then 3, 6 and 12 months after surgery. We examined whether there were any differences in the rate of HPV DNA positivity after LLETZ between specific risk groups, such as patients with primary (i.e. before surgical treatment) high-risk HPV infection, CIN of different grades, and positive margins.
RESULTS: We did not detect statistically significant differences between specific risk groups. According to the assay used (hybrid capture II) at the last follow-up visit 94% of primarily infected patients were completely free from infection with high-risk HPV types, while 6% had persisting HPV infection.
CONCLUSIONS: With a detection limit of 5000 genomes/ml HPV DNA the hybrid capture II results revealed, that after electrosurgical removal of CIN in 94% of patients testing positive for high-risk HPV DNA prior to surgery were negative 12 months post-surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728661     DOI: 10.1016/s0301-2115(01)00457-2

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  9 in total

1.  Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.

Authors:  Jeong-Yeol Park; Jaeman Bae; Myong Cheol Lim; So Yi Lim; Dong-Ock Lee; Sokbom Kang; Sang-Yoon Park; Byung-Ho Nam; Sang-Soo Seo
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

2.  The safety and efficacy of a novel method for treatment of HSIL.

Authors:  Jian Zhao; Hui Feng; Tingting Wang; Xiaocong Pang; Yingfang Zhou; Yimin Cui
Journal:  Arch Gynecol Obstet       Date:  2021-04-03       Impact factor: 2.344

3.  Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.

Authors:  Akiko Kudoh; Shinya Sato; Hiroaki Itamochi; Hiroaki Komatsu; Michiko Nonaka; Seiya Sato; Jun Chikumi; Muneaki Shimada; Tetsuro Oishi; Junzo Kigawa; Tasuku Harada
Journal:  Int J Clin Oncol       Date:  2015-11-27       Impact factor: 3.402

Review 4.  Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review.

Authors:  Benjamin K S Chan; Joy Melnikow; Christina A Slee; Rose Arellanes; George F Sawaya
Journal:  Am J Obstet Gynecol       Date:  2009-01-24       Impact factor: 8.661

5.  Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization.

Authors:  Hyeyoon Chang; Jin Hwa Hong; Jae Kwan Lee; Hyun Woong Cho; Yung Taek Ouh; Kyung Jin Min; Kyeong A So
Journal:  J Gynecol Oncol       Date:  2018-01-29       Impact factor: 4.401

6.  Outcomes of Laser Conization for Cervical Intraepithelial Neoplasia 2-3 and Microinvasive Cervical Cancer.

Authors:  Seiji Kanayama; Eriko Nakagawa; Sayaka Ueno; Miho Muraji; Senn Wakahashi; Tamotsu Sudo; Takashi Yamada; Satoshi Yamaguchi; Kiyoshi Fujiwara; Ryuichiro Nishimura
Journal:  World J Oncol       Date:  2014-05-06

7.  Diagnostic excision of the cervix in women over 40 years with human papilloma virus persistency and normal cytology.

Authors:  Riina Aarnio; Ingrid Wikström; Inger Gustavsson; Ulf Gyllensten; Matts Olovsson
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-08

8.  Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.

Authors:  Mojgan Karimi-Zarchi; Leila Allahqoli; Ameneh Nehmati; Abolfazl Mehdizadeh Kashi; Shokouh Taghipour-Zahir; Ibrahim Alkatout
Journal:  BMC Public Health       Date:  2020-02-27       Impact factor: 3.295

9.  Human Papilloma Virus Persistence after Cone Excision in Women with Cervical High Grade Squamous Intraepithelial Lesion: A Prospective Study.

Authors:  Laurențiu Pirtea; Dorin Grigoraş; Petru Matusz; Marilena Pirtea; Lavinia Moleriu; Anca Tudor; Răzvan Ilina; Cristina Secoşan; Florin Horhat; Octavian Mazilu
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-12       Impact factor: 2.471

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.